News

DMV-Fonterra Excipients, the 50/50 joint venture between Royal FrieslandCampina and Fonterra for pharmaceutical excipients, has reported to buy the activities of FrieslandCampina Domo in pharmaceutical lactose as per

Intercell has started a phase II study in India as part of its clinical development program, for the investigational travelers’ diarrhea (TD) vaccine system. This placebo controlled field

Cardium Therapeutics (Cardium) has planned to launch a new premium advanced skin care product line to promote foot health and comfort for podiatry patients. Cardium’s new MedPodium product

MonoSol Rx has entered into a new licensing and development agreement that grants the option to develop three new products with Strativa Pharmaceuticals (Strativa). Strativa has the option

Anteis and Sanofi-aventis have entered into a supply and distribution partnership for Succeev, a Hyaluronic Acid (HA) based dermal filler. Available in Europe, Asia-Pacific, South America and the

The European Commission (EC) has approved Pfizer’s Revatio (sildenafil) solution for injection in patients who are currently prescribed oral Revatio and who are temporarily unable to take oral

India-based Zydus Cadila has received an approval from the Drug Controller General of India (DCGI) to conduct clinical trials for the H1N1 (swine flu) vaccine. The egg based,

ImmuneRegen BioSciences (ImmuneRegen) has presented additional positive results from a recent study that evaluated its lead anti-influenza drug, Homspera, in ferrets. The study performed at a public University

China Aoxing Pharmaceutical (China Aoxing) has completed Phase II clinical study for oral TJSL capsules, an investigational drug to treat primary dysmenorrhea (PD) , or menstrual pain, in